• CWG0816
    $MSTX beats Q4 earnings by .01. "The Company also is developing MST-188 in heart failure and plans...
    3/26/14
    Reply (2)
    • CWG0816: to announce its clinical development plans in this indication in the second half of 2014".
      3/26/14
    • zzx375: And it is dropping.
      3/26/14